415 mg (Highly purified phospholipids, Diindolylmethane, Quercetin Dihydrate (from Sophora japonica flower), Milk Thistle Seed Extract (80% Silymarin), Resveratrol (from Polygonum cuspidatum root), Berberine HCL (from Phellodendron amurense bark), Cinnamon bark oil) Other Ingredients: Glycerin, water, ethanol, medium chain triglycerides, tocofersolan, natural citrus oils, natural flavoring, natural mixed tocopherols, propolis extract If pregnant or breastfeeding consult your heathcare practitioner before use
"Farxiga (Dapagliflozin) Tablets." FDA, Accessed October 4, 2023, www.accessdata.fda.gov/drugsatfda_docs/label/2021/202293s024lbl.pdf
Is DSIP approved
15% from injections in clinical trials.) Potential side effects and risks of oral semaglutide The most common side effects of oral semaglutide include: Stomach pain Diarrhea Decreased appetite Vomiting Typically, these gastrointestinal side effects are most common when starting treatment and when increasing your dose
doi: 10.1038/sj.ijo.0801083 Summary Keywords Prader-Willi syndrome, obesity, GLP-1 receptor agonist, semaglutide, metabolic surgery Citation Koceva A, Mleku Kozamernik K, Jane A, Herman R, Ferjan S and Jensterle M (2025) Case report: Long-term efficacy and safety of semaglutide in the treatment of syndromic obesity in Prader Willi syndrome - case series and literature review